• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • Myinsights
  • MYBoard
  • Strategy & Consulting
Select Page

Linerixibat Significantly Improves PBC-Related Cholestatic Pruritus in Adult Patients

by MM360 Staff | May 20, 2025 | Myeloma News | 0 comments

Source: Pharmacy Times articles

Compared with placebo, patients with cholestatic pruritus and primary biliary cholangitis (PBC) receiving linerixibat experienced improved itch and sleep interference.
Read More

Submit a Comment Cancel reply

You must be logged in to post a comment.

Recent Content

  • Finding Meaning After an Acute Myeloid Leukemia Diagnosis
  • Early Arterial Thrombosis May Signal Future Cancer Risk
  • Glofit-GemOx in R/R DLBCL: FDA Advisory Committee Reviews STARGLO Phase 3 Results for Transplant-Ineligible Patients
  • What are the Long-Term Side Effects of Proton Therapy in Prostate Cancer?
  • Mentorship, Leadership, and Professional Growth in Oncology Pharmacy
  • Triple-Combination Therapy Met Primary End Point in Phase 3 Trials, Providing Treatment for Individuals With Asthma
  • The Unnamed Nurse who Saved My Life During Breast Cancer
  • Declines in Pediatric Pneumococcal Complicated Pneumonia Evident Following Introduction of Higher Valent Vaccines
  • Acoustic Cluster Therapy Shows Benefit in Colorectal Liver Metastases
  • Understanding the Toxicity Profiles of Fat-Soluble Vitamins: Insights Into Vitamins A, D, E, and K
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT